“Anker was a key advisory board member who provided some of the most sanguine and forthright advice about our brand at a time the business needed to make a strategic shift: as a result we took a calculated but significant risk which paid off.”
Activity
-
#Asceneuron_sa announces $100 million oversubscribed Series C financing! Today we announce that we have successfully secured a Series C financing…
#Asceneuron_sa announces $100 million oversubscribed Series C financing! Today we announce that we have successfully secured a Series C financing…
Liked by Anker Lundemose
-
Big well done to the Asceneuron SA team for completing this Series C to continue the development of ASN51. We are proud to continue supporting the…
Big well done to the Asceneuron SA team for completing this Series C to continue the development of ASN51. We are proud to continue supporting the…
Liked by Anker Lundemose
-
This morning, we announced the appointment of Lucinda Crabtree, PhD as Chief Financial Officer and Board Member following Stuart Paynter’s decision…
This morning, we announced the appointment of Lucinda Crabtree, PhD as Chief Financial Officer and Board Member following Stuart Paynter’s decision…
Liked by Anker Lundemose
Recommendations received
1 person has recommended Anker
Join now to viewMore activity by Anker
-
🧪𝐖𝐨𝐦𝐞𝐧 𝐈𝐧 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐟𝐞𝐚𝐭. 𝐒𝐚𝐫𝐚𝐡 𝐀𝐥𝐦𝐨𝐧𝐝 Meet Sarah Almond, the VP Pharmacology at Mission Therapeutics, a clinical phase…
🧪𝐖𝐨𝐦𝐞𝐧 𝐈𝐧 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐟𝐞𝐚𝐭. 𝐒𝐚𝐫𝐚𝐡 𝐀𝐥𝐦𝐨𝐧𝐝 Meet Sarah Almond, the VP Pharmacology at Mission Therapeutics, a clinical phase…
Liked by Anker Lundemose
-
I am happy to share that I am a member of the 2024 Women In Bio Boardroom Ready Cohort. This executive development program is designed to fuel…
I am happy to share that I am a member of the 2024 Women In Bio Boardroom Ready Cohort. This executive development program is designed to fuel…
Liked by Anker Lundemose
-
We're #hiring a Director of in vivo pharmacology to our in vivo team Commit Biologics. Apply today or share this post with your…
We're #hiring a Director of in vivo pharmacology to our in vivo team Commit Biologics. Apply today or share this post with your…
Liked by Anker Lundemose
-
A nice summary of our #MTX325 trial and award from The Michael J. Fox Foundation for Parkinson's Research and Parkinson's UK in this week's…
A nice summary of our #MTX325 trial and award from The Michael J. Fox Foundation for Parkinson's Research and Parkinson's UK in this week's…
Liked by Anker Lundemose
-
Congratulations to Campus-based Mission Therapeutics on being awarded $5.2m from The The Michael J. Fox Foundation for Parkinson's Research and…
Congratulations to Campus-based Mission Therapeutics on being awarded $5.2m from The The Michael J. Fox Foundation for Parkinson's Research and…
Liked by Anker Lundemose
-
Mission Therapeutics has been awarded $5.2 million from The Michael J. Fox Foundation for Parkinson's Research (MJFF) and Parkinson's UK. The funding…
Mission Therapeutics has been awarded $5.2 million from The Michael J. Fox Foundation for Parkinson's Research (MJFF) and Parkinson's UK. The funding…
Liked by Anker Lundemose
-
📢 Amazing news that The Michael J. Fox Foundation for Parkinson's Research and Parkinson's UK have awarded $5.2m to portfolio company Mission…
📢 Amazing news that The Michael J. Fox Foundation for Parkinson's Research and Parkinson's UK have awarded $5.2m to portfolio company Mission…
Liked by Anker Lundemose
-
Congratulations Mission Therapeutics, especially Paul Thompson and the clinical team at Mission. I wish you all the best on progressing this compound…
Congratulations Mission Therapeutics, especially Paul Thompson and the clinical team at Mission. I wish you all the best on progressing this compound…
Liked by Anker Lundemose
-
A proud day to be part of the MTX325 journey.
A proud day to be part of the MTX325 journey.
Liked by Anker Lundemose
-
Mission Therapeutics is thrilled to announce that it has been awarded $5.2 million from The Michael J. Fox Foundation for Parkinson’s Research…
Mission Therapeutics is thrilled to announce that it has been awarded $5.2 million from The Michael J. Fox Foundation for Parkinson’s Research…
Liked by Anker Lundemose
-
Great news that The Danish Government has agreed on a new package that removes two taxes on entrepreneurship and increase the incentive for Danish…
Great news that The Danish Government has agreed on a new package that removes two taxes on entrepreneurship and increase the incentive for Danish…
Liked by Anker Lundemose
-
Our CEO Anker Lundemose spoke to Megan Thomas from Drug Discovery World about exploring new frontiers in Parkinson’s Disease. Anker provided insight…
Our CEO Anker Lundemose spoke to Megan Thomas from Drug Discovery World about exploring new frontiers in Parkinson’s Disease. Anker provided insight…
Liked by Anker Lundemose
-
Laura Parton, our Senior Director of Project Management, will be presenting at the 2024 BioBabraham Campus Symposium. Laura will present on the…
Laura Parton, our Senior Director of Project Management, will be presenting at the 2024 BioBabraham Campus Symposium. Laura will present on the…
Liked by Anker Lundemose
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More